Application
LDB3 Antibody (Center) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the LDB3 antibody detected the LDB3 protein (arrow).| Product Name | LDB3 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LDB3; KIAA0613; ZASP; LIM domain-binding protein 3; Protein cypher; Z-band alternatively spliced PDZ-motif protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA0613 ZASP |
|---|---|
| Alternative Names | LDB3 KIAA0613 ZASP LIM domain-binding protein 3 Protein cypher Z-band alternatively spliced PDZ-motif protein |
| Molecular Weight(MW) | 77135 Da |
| Function | May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton |
| Tissue Specificity | Expressed primarily in skeletal muscle and to a lesser extent in heart. Also detected in brain and placenta |
| Cellular Localization | Cytoplasm, perinuclear region. Cell projection, pseudopodium. Cytoplasm, cytoskeleton. Cytoplasm, myofibril, sarcomere, Z line. Note=Localized to the cytoplasm around nuclei and pseudopodia of undifferentiated cells and detected throughout the myotubes of differentiated cells Colocalizes with ACTN2 at the Z-lines |
| Entrez Gene | 11155 |
|---|---|
| Nucleotide Accession | NP_001073584.1 NP_001073583.1 |
Application
LDB3 Antibody (Center) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the LDB3 antibody detected the LDB3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
